CLOs on the Move

Xagenic

www.xagenic.com

 
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.xagenic.com
  • 55 York Street Suite 1000
    Toronto, ON CAN M5J 1R7
  • Phone: 416.363.1999

Executives

Name Title Contact Details

Similar Companies

CareerSource Heartland

CareerSource Heartland is a not-for-profit corporation that operates as a demand-driven and business focused public-private partnership. Through oversight provided by the local elected officials from DeSoto, Hardee, and Highlands counties, our Board of Directors offer workforce development related growth opportunities to Business Customers and Job Seekers throughout our Tri-County service delivery area. As one of twenty-four Regional Workforce Boards in Florida, we oversee the workforce and talent development activities in the tri-county region, collaborating with numerous private and public sector organizations and businesses to enhance the local economy. Our Board has a diversified membership with a majority of the members from the private (business) sector. The Board also includes representatives from secondary and post-secondary education institutions, Economic Development commissions, and community based organizations.

Meadowview Manor Retirement HM

Meadowview Manor Retirement HM is a Mc Veytown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Worldcare Limited

Worldcare Limited is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.

HPS Group

HPS Group is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.